SignatureFD’s TriSalus Life Sciences TLSI Stock Holding History

SignatureFD’s Portfolio TLSI Stock Details TLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$431	Hold	100	–	–	﹤0.01%	3426
2026 Q2	$455	Hold	100	–	–	﹤0.01%	3375
2026 Q1	$400	Hold	100	–	–	﹤0.01%	3337
2025 Q4	$698	Hold	100	–	–	﹤0.01%	3173
2025 Q3	$465	Hold	100	–	–	﹤0.01%	3200
2025 Q2	$545	Hold	100	–	–	﹤0.01%	3091
2025 Q1	$552	Hold	100	–	–	﹤0.01%	3155
2024 Q4	$501	Hold	100	–	–	﹤0.01%	3141
2024 Q3	$461	Hold	100	–	–	﹤0.01%	3110
2024 Q2	$552	Hold	100	–	–	﹤0.01%	2979
2024 Q1	$975	Buy	+100	New	+$923	﹤0.01%	2955

Other funds holding TLSI

Perkins Capital Management Wayzata, Minnesota $140M AUM 109.55% 1-Year Est. Return

CWA Asset Management Group Naples, Florida $3.39B AUM 25.16% 1-Year Est. Return

Connecticut Wealth Management Farmington, Connecticut $2.73B AUM 14.39% 1-Year Est. Return

Provenance Wealth Advisors Fort Lauderdale, Florida $1.69B AUM 11.53% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $45.2B AUM 20.72% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

SJS Investment Consulting Sylvania, Ohio $993M AUM 16.29% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

SignatureFD's TLSI Position: Q3 2026 in Review

SignatureFD held its TriSalus Life Sciences (TLSI) position steady in Q3 2026 at 100 shares worth $431. The position accounts for ﹤0.01% of the portfolio, ranked #3426.

SignatureFD first reported a position in TLSI in Q1 2024 and has held it in 11 quarters since. The position peaked at $975 in Q1 2024. 17 funds tracked by Wall St. Rank hold TLSI as of Q3 2026.

SignatureFD held 100 shares of TriSalus Life Sciences worth $431 as of Q3 2026.
SignatureFD left its TriSalus Life Sciences share count unchanged in Q3 2026.
TriSalus Life Sciences made up ﹤0.01% of SignatureFD's portfolio in Q3 2026, its #3426 holding.
SignatureFD first reported a position in TriSalus Life Sciences in Q1 2024 and has held it in 11 quarters since.
SignatureFD's TriSalus Life Sciences position peaked at $975 in Q1 2024.
17 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q3 2026.

Based on SignatureFD's 13F filing for Q3 2026, filed 23 Oct 2026.